327 related articles for article (PubMed ID: 12434014)
1. Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.
Sawkar AR; Cheng WC; Beutler E; Wong CH; Balch WE; Kelly JW
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15428-33. PubMed ID: 12434014
[TBL] [Abstract][Full Text] [Related]
2. Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease.
Yu L; Ikeda K; Kato A; Adachi I; Godin G; Compain P; Martin O; Asano N
Bioorg Med Chem; 2006 Dec; 14(23):7736-44. PubMed ID: 16919960
[TBL] [Abstract][Full Text] [Related]
3. Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin.
Luan Z; Higaki K; Aguilar-Moncayo M; Ninomiya H; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chembiochem; 2009 Nov; 10(17):2780-92. PubMed ID: 19830760
[TBL] [Abstract][Full Text] [Related]
4. A comparative computational approach toward pharmacological chaperones (NN-DNJ and ambroxol) on N370S and L444P mutations causing Gaucher's disease.
Thirumal Kumar D; Iyer S; Christy JP; Siva R; Tayubi IA; George Priya Doss C; Zayed H
Adv Protein Chem Struct Biol; 2019; 114():315-339. PubMed ID: 30635084
[TBL] [Abstract][Full Text] [Related]
5. Promising results of the chaperone effect caused by imino sugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease.
Sánchez-Ollé G; Duque J; Egido-Gabás M; Casas J; Lluch M; Chabás A; Grinberg D; Vilageliu L
Blood Cells Mol Dis; 2009; 42(2):159-66. PubMed ID: 19167250
[TBL] [Abstract][Full Text] [Related]
6. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
Alfonso P; Pampín S; Estrada J; Rodríguez-Rey JC; Giraldo P; Sancho J; Pocoví M
Blood Cells Mol Dis; 2005; 35(2):268-76. PubMed ID: 16039881
[TBL] [Abstract][Full Text] [Related]
7. Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
Sawkar AR; Adamski-Werner SL; Cheng WC; Wong CH; Beutler E; Zimmer KP; Kelly JW
Chem Biol; 2005 Nov; 12(11):1235-44. PubMed ID: 16298303
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease.
Brumshtein B; Greenblatt HM; Butters TD; Shaaltiel Y; Aviezer D; Silman I; Futerman AH; Sussman JL
J Biol Chem; 2007 Sep; 282(39):29052-29058. PubMed ID: 17666401
[TBL] [Abstract][Full Text] [Related]
9. The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms.
Steet RA; Chung S; Wustman B; Powe A; Do H; Kornfeld SA
Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13813-8. PubMed ID: 16945909
[TBL] [Abstract][Full Text] [Related]
10. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
[TBL] [Abstract][Full Text] [Related]
11. Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
Diot JD; Garcia Moreno I; Twigg G; Ortiz Mellet C; Haupt K; Butters TD; Kovensky J; Gouin SG
J Org Chem; 2011 Oct; 76(19):7757-68. PubMed ID: 21830816
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of N-substituted ε-hexonolactams as pharmacological chaperones for the treatment of N370S mutant Gaucher disease.
Wang GN; Twigg G; Butters TD; Zhang S; Zhang L; Zhang LH; Ye XS
Org Biomol Chem; 2012 Apr; 10(15):2923-7. PubMed ID: 22286559
[TBL] [Abstract][Full Text] [Related]
13. Diltiazem, a L-type Ca(2+) channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells.
Rigat B; Mahuran D
Mol Genet Metab; 2009 Apr; 96(4):225-32. PubMed ID: 19167257
[TBL] [Abstract][Full Text] [Related]
14. The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.
Khanna R; Benjamin ER; Pellegrino L; Schilling A; Rigat BA; Soska R; Nafar H; Ranes BE; Feng J; Lun Y; Powe AC; Palling DJ; Wustman BA; Schiffmann R; Mahuran DJ; Lockhart DJ; Valenzano KJ
FEBS J; 2010 Apr; 277(7):1618-38. PubMed ID: 20148966
[TBL] [Abstract][Full Text] [Related]
15. Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention.
Yu Z; Sawkar AR; Whalen LJ; Wong CH; Kelly JW
J Med Chem; 2007 Jan; 50(1):94-100. PubMed ID: 17201413
[TBL] [Abstract][Full Text] [Related]
16. A Fluorescent sp2-iminosugar with pharmacological chaperone activity for gaucher disease: synthesis and intracellular distribution studies.
Luan Z; Higaki K; Aguilar-Moncayo M; Li L; Ninomiya H; Nanba E; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chembiochem; 2010 Nov; 11(17):2453-64. PubMed ID: 21064079
[TBL] [Abstract][Full Text] [Related]
17. N-octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease.
Lin H; Sugimoto Y; Ohsaki Y; Ninomiya H; Oka A; Taniguchi M; Ida H; Eto Y; Ogawa S; Matsuzaki Y; Sawa M; Inoue T; Higaki K; Nanba E; Ohno K; Suzuki Y
Biochim Biophys Acta; 2004 Aug; 1689(3):219-28. PubMed ID: 15276648
[TBL] [Abstract][Full Text] [Related]
18. Enzyme enhancement activity of N-octyl-beta-valienamine on beta-glucosidase mutants associated with Gaucher disease.
Lei K; Ninomiya H; Suzuki M; Inoue T; Sawa M; Iida M; Ida H; Eto Y; Ogawa S; Ohno K; Suzuki Y
Biochim Biophys Acta; 2007 May; 1772(5):587-96. PubMed ID: 17363227
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological chaperones facilitate the post-ER transport of recombinant N370S mutant β-glucocerebrosidase in plant cells: evidence that N370S is a folding mutant.
Babajani G; Tropak MB; Mahuran DJ; Kermode AR
Mol Genet Metab; 2012 Jul; 106(3):323-9. PubMed ID: 22592100
[TBL] [Abstract][Full Text] [Related]
20. Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants.
Sawkar AR; Schmitz M; Zimmer KP; Reczek D; Edmunds T; Balch WE; Kelly JW
ACS Chem Biol; 2006 May; 1(4):235-51. PubMed ID: 17163678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
